Semaglutide Tracker: What to Track (Ozempic, Wegovy, Rybelsus)
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.
Quick answer
A semaglutide tracker logs your dose, injection site or pill timing, weight trend, protein & side effects across Ozempic, Wegovy & Rybelsus. Here's what to track.
Semaglutide is a single GLP-1 receptor agonist — one molecule — sold under three brand names: Ozempic (weekly injection for type 2 diabetes), Wegovy (weekly injection for chronic weight management), and Rybelsus (a daily oral tablet for type 2 diabetes).
It is not the same drug as tirzepatide (Mounjaro, Zepbound), which is a different, dual-hormone molecule.
Because the same active ingredient comes in different doses, routes, and schedules, the one thing every semaglutide plan rewards is clean record-keeping.
This guide covers what to track on semaglutide, how tracking differs between the injectable and oral forms, and how brand versus compounded semaglutide changes the picture.
It is neutral and educational — you can do all of it on paper.
If you already know your specific brand, jump to the brand-specific guides: our Ozempic tracker guide and Wegovy tracker guide.
If you want the general framework across all GLP-1s first, start with the complete GLP-1 tracker app guide.
01
What is semaglutide? One molecule, three brands
Semaglutide mimics the gut hormone GLP-1, which slows gastric emptying and acts on appetite centers in the brain (Cleveland Clinic).
The confusion most people hit is that the same molecule is marketed under three names with different indications, doses, and schedules.
Here is the map — and it is exactly why a tracker matters.
(Doses per the FDA labels — see References. Off-label prescribing happens; always follow your own prescriber and label.)
The takeaway: whichever brand you are on, you are on semaglutide — but the schedule you must track is different for each. That is what the rest of this guide unpacks.
02
Why tracking matters on semaglutide specifically
Three features of semaglutide make tracking more than a nice-to-have:
The dose escalates on a schedule.
Every semaglutide brand starts low and steps up over weeks to reduce gastrointestinal side effects. Logging which dose you took on which date keeps you synced to that plan and gives your prescriber an exact history at adjustment visits.
The timing is easy to miss.
A weekly injection is easy to forget or delay; a daily pill has strict fasting rules that are easy to break. Either way, a timestamped log turns a stressful "did I?" into a glance.
Results and side effects are non-linear.
Weight comes off in fits and plateaus, and nausea tends to spike right after each dose increase. Only a trend — not a single day — shows what is actually happening.
03
What to track on semaglutide (and why each one matters)
Here is the core semaglutide dataset. Use it as your checklist whether you inject (Ozempic/Wegovy) or take the oral tablet (Rybelsus), on paper, in a spreadsheet, or in an app.
| What to track | Why it matters | How often |
|---|---|---|
| Dose date & amount (mg) | Keeps you aligned with the titration schedule; confirms adherence; prevents accidental double-dosing | Every dose (weekly injection / daily pill) |
| Injection site & rotation (injectable) | Rotating sites prevents lumpy scar tissue (lipohypertrophy) that changes drug absorption | Every injection |
| Pill timing & fasting window (oral) | Rybelsus only absorbs correctly on an empty stomach with the right water and wait | Every morning dose |
| Body weight | The primary outcome; the trend reveals plateaus and metabolic adaptation | 1–3× per week, same time of day |
| Waist / measurements | Catches fat loss the scale misses, especially while preserving muscle | Every 1–2 weeks |
| Protein intake (grams) | Protects lean muscle mass, which is at risk during rapid weight loss | Daily |
| Water / hydration | Eases the constipation and nausea common in the first weeks | Daily |
| Side effects & severity | Separates normal adaptation from red-flag symptoms needing a doctor | As they occur |
| Blood sugar (if diabetic) | Ozempic and Rybelsus are diabetes medicines; glucose is a core outcome | Per your care plan |
| Refill / supply | A weekly pen or a daily pill pack runs out on a predictable date; avoids a coverage gap | Monthly |
04
Injectable vs oral semaglutide: what changes about tracking
This is the fork that trips people up. The active ingredient is identical, but what you record depends on whether you inject or swallow it.
Injectable semaglutide (Ozempic & Wegovy)
Both injectable brands are given subcutaneously into the abdomen (at least two inches from the navel), the front of the thigh, or the upper arm, rotating each week (wegovy.com pen guide; ozempic.com dosing).
Repeatedly injecting the same spot can cause lipohypertrophy — lumpy scar tissue that changes absorption.
Track which mg you took, on what date, at which site. Their titration schedules differ:
- Ozempic steps 0.25 mg (weeks 1–4, a starting dose, not for glycemic control) → 0.5 mg → 1 mg → up to a 2 mg maximum, as your prescriber directs (FDA Ozempic label).
- Wegovy steps 0.25 → 0.5 → 1 → 1.7 → 2.4 mg maintenance (novoMEDLINK Wegovy dosing).
Because the two brands top out at different doses, a dose log removes any doubt about where you are in your specific schedule.
See our Ozempic tracker and Wegovy tracker for the brand-by-brand detail.
Oral semaglutide (Rybelsus)
Rybelsus is a different tracking problem: it is a once-daily tablet with strict timing rules. Per Novo Nordisk and the FDA label, take it first thing in the morning on an empty stomach, with no more than 4 oz (about 120 mL) of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking other medicines (novoMEDLINK Rybelsus dosing; FDA Rybelsus label).
Swallow the tablet whole — do not split, crush, or chew.
Its titration is 3 mg for 30 days → 7 mg → 14 mg. For oral users, the tracker's job is a daily reminder plus the fasting window, not an injection-site map — because breaking the empty-stomach rule quietly cuts absorption.
05
Missed-dose rules differ by brand — do not mix them up
This is the single most confused semaglutide fact, and getting it wrong on the wrong brand matters. Log every dose with a timestamp so the decision is a glance, not a guess.
| Brand | Missed-dose rule |
|---|---|
| Wegovy (weekly) | If the next dose is more than 2 days (48 h) away, take the missed dose ASAP; if less than 2 days away, skip it and resume on schedule |
| Ozempic (weekly) | Take the missed dose ASAP within 5 days; if more than 5 days have passed, skip it and resume on schedule (don't take two doses within 48 h) |
| Rybelsus (daily) | Skip the missed dose entirely and take the next dose the following day — do not double up |
Sources: novoMEDLINK Wegovy dosing; FDA Ozempic label; FDA Rybelsus label.
Always follow your own label and prescriber — this is education, not direction.
06
Brand vs compounded semaglutide: what to track and know
You may have seen "compounded semaglutide" offered by telehealth clinics or med-spas, often cheaper than brand-name pens.
Here is the regulatory reality as of 2026, because it affects what you are actually injecting.
- Brand-name semaglutide (Ozempic, Wegovy, Rybelsus) is FDA-approved — reviewed for safety, efficacy, and manufacturing quality.
- Compounded semaglutide is not FDA-approved. Compounding was widely allowed only while semaglutide was on the FDA drug-shortage list. The FDA declared that shortage resolved on February 21, 2025, and set enforcement deadlines: 503A pharmacies until April 22, 2025 and 503B outsourcing facilities until May 22, 2025 (FDA compounding policy statement).
- After those dates, routine large-scale compounding of copies of approved semaglutide is no longer permitted; only narrow patient-specific 503A exceptions (e.g., a documented excipient allergy, or a strength not commercially available) may remain.
If you are on a compounded product, track the exact source, concentration, and dose in your own units carefully — compounded formulations can differ in strength and units from brand pens, which is a documented dosing-error risk.
When in doubt, ask a licensed pharmacist or your prescriber, and prefer FDA-approved products.
07
Semaglutide vs tirzepatide: not the same molecule
A common mix-up: semaglutide is a single GLP-1 receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual GIP + GLP-1 receptor agonist — a different molecule that acts on two hormone pathways and, in head-to-head trials, produced greater average weight loss.
If you are deciding between them, or switching, that is a separate conversation covered in our semaglutide vs tirzepatide guide.
For tracking purposes, the two are not interchangeable: never log a tirzepatide dose against a semaglutide schedule.
08
How to build a semaglutide tracking routine in 6 steps
You do not need a complicated system — you need a repeatable one. The core log takes under two minutes a week (or one tap a morning for Rybelsus), plus quick daily taps.
- 1
Set a dose reminder that matches your form.
A recurring weekly alert for Ozempic/Wegovy, or a daily morning alarm for Rybelsus so the fasting window isn't missed.
- 2
Log the dose right after taking it.
Record the mg amount and — if injecting — mark the body-map zone so next week's rotation is obvious.
- 3
Weigh in on fixed days.
Choose 1–3 mornings a week, same conditions, and read the trend — not the daily noise.
- 4
Track protein and water daily.
A quick tap per meal keeps muscle protection on track.
- 5
Note side effects when they happen.
Record the symptom, severity, and days since your last dose or dose increase.
- 6
Photo every 2–4 weeks and review before each visit.
Same lighting, same angle — and bring your dose log and side-effect timeline to your clinician.
09
Do you need a semaglutide app, or is a notebook fine?
Honestly, any tracking beats none — a semaglutide diary in a notebook works.
What an app adds is the automation of the parts people forget: the dose reminder tuned to weekly-vs-daily, the injection-site rotation map for the pens, the trend line that smooths daily weight noise, and a side-effect timeline you can hand to your clinician.
None of the three brands ships with a dedicated companion app, so most people use a general GLP-1 or wellness tracker.
If you want your dose log living next to the daily habits that protect your results — protein, movement, hydration, weight and body-composition trends — a wellness app like HAVIT is a natural home for it.
Compare options in our best GLP-1 tracker apps guide and pick what you will actually keep using; consistency matters far more than the brand.
10
Related guides
- Ozempic tracker: what to log on Ozempic and how
- Wegovy tracker: what to track on Wegovy and how
- Semaglutide vs. tirzepatide: which GLP-1 is right for you?
- The complete GLP-1 tracker app guide
11
Why HAVIT — Medication + Behavior Change, in One App
GLP-1 medications can meaningfully reduce weight — but the number on the scale is only part of the story.
Roughly 20–40% of the weight lost on GLP-1 therapy can come from lean (muscle) tissue rather than fat (Neeland et al., Diabetes, Obesity and Metabolism, 2024), and results tend to fade once the medication stops unless new habits take their place.
That's why leading guidance treats medication as one part of care, not the whole: the U.S. Preventive Services Task Force recommends that adults with obesity be offered intensive, multicomponent behavioral interventions (USPSTF, Grade B).
HAVIT is built for exactly this moment — one app that unites medication tracking, body composition, nutrition and protein, daily habit-building, and an AI coach that adapts to you.
Across our own 1,090 GLP-1 users, the most consistent trackers built the strongest habits (see the GLP-1 habit report).
Manage the medicine and the muscle — together. Start with HAVIT →
What is semaglutide? One molecule, three brands
| Brand | Form & schedule | FDA-approved use | Dose range |
|---|---|---|---|
| Ozempic | Once-weekly injection | Type 2 diabetes | 0.25 → 0.5 → 1 → up to 2 mg |
| Wegovy | Once-weekly injection | Chronic weight management | 0.25 → 0.5 → 1 → 1.7 → 2.4 mg |
| Rybelsus | Daily oral tablet | Type 2 diabetes | 3 → 7 → 14 mg |
Frequently asked questions
What is a semaglutide tracker?
Are Ozempic, Wegovy, and Rybelsus the same drug?
How is tracking oral semaglutide (Rybelsus) different?
What is the semaglutide dose schedule I should log?
What happens if I miss a semaglutide dose?
Is compounded semaglutide the same as the brand?
Is semaglutide the same as tirzepatide?
Is there an official semaglutide tracking app?
What is Havit?
Havit is an AI health companion for weight loss that protects muscle.
Unlike calorie-only trackers, Havit connects AI body-composition estimates, nutrition, hydration, sleep, steps, cycle, mood, and GLP-1 medication in one daily routine — so progress is measured by body composition, not just the number on the scale. Daily missions turn established behavior-change techniques into small repeatable actions, drawing on expertise from professionals formerly at Juvis Diet, one of Korea’s leading metabolic clinics.
In Havit’s own analysis of 1,090 GLP-1 users, people who logged consistently built stronger habits than the general user base. Read the GLP-1 Habit Report
Havit works with or without GLP-1 medication. It is a wellness app, not a medical device; body-composition results are estimates.
Continue in the App
Personalized wellness with your own data
References
- U.S. Food & Drug Administration — Ozempic (semaglutide) injection, prescribing information (dose escalation, missed dose within 5 days). accessdata.fda.gov accessdata.fda.gov
- U.S. Food & Drug Administration — Wegovy (semaglutide) prescribing information (2.4 mg escalation, 2-day missed-dose rule). accessdata.fda.gov accessdata.fda.gov
- U.S. Food & Drug Administration — Rybelsus (semaglutide) tablets, prescribing information (3/7/14 mg, empty-stomach administration, skip missed dose). accessdata.fda.gov accessdata.fda.gov
- Novo Nordisk (novoMEDLINK) — Rybelsus dosing & administration (take with ≤4 oz water, wait ≥30 minutes). novomedlink.com novomedlink.com
- Novo Nordisk (novoMEDLINK) — Wegovy dosing & administration: escalation and 2-day missed-dose guidance. novomedlink.com novomedlink.com
- Novo Nordisk — Ozempic pen dosing & administration. ozempic.com ozempic.com
- U.S. Food & Drug Administration — FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (semaglutide shortage resolved Feb 21, 2025; 503A/503B deadlines). fda.gov fda.gov
- Cleveland Clinic — GLP-1 agonists: uses, how they work, and side effects. my.clevelandclinic.org my.clevelandclinic.org
- Mayo Clinic — Semaglutide (subcutaneous route): description and proper use. mayoclinic.org mayoclinic.org
- Frontiers in Clinical Diabetes and Healthcare (via PMC) — GLP-1 agonists, lean-mass loss, and the role of exercise and protein. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
- All medical claims verified against the cited FDA labels, Novo Nordisk materials, and FDA compounding statements as of July 2026. Re-review at least every 12 months or sooner if an FDA label changes.*
